Q4 2025 TOMI Environmental Solutions Inc Earnings Call Transcript
Key Points
- TOMI Environmental Solutions Inc (TOMZ) achieved its first commercial installation of the SteraMist Integrated System (SIS) in 2025, with four fully operational installations by year-end.
- The company secured a significant $500,000 purchase contract with a global biopharmaceutical leader and expanded its presence in the cell and gene therapy sector.
- TOMZ was selected by NASA Johnson Space Center for a biosecurity operation, highlighting the effectiveness of its technology.
- The company expanded into the agriculture industry through a partnership with AlgaFeed and received FDA approval for hydrogen peroxide as a direct food additive.
- TOMZ's gross margin improved to approximately 55% in 2025, up from 46% in 2024, reflecting lower cost of sales and reduced inventory reserves.
- Revenue for 2025 was $5.6 million, a decline from $7.7 million in 2024, primarily due to the timing of customer equipment purchases.
- The company ended 2025 with only $88,000 in cash, indicating a challenging liquidity position.
- TOMZ reported a net loss of $3.7 million for 2025, although this was an improvement from a $4.5 million loss in 2024.
- The company faced challenges such as tariffs, political uncertainty, and the impact of the Middle East crisis, which affected customer capital expenditure projects.
- Despite a strong pipeline, TOMZ's stock price declined to $0.78 by the end of 2025, reflecting market concerns over financial performance.
Good day, and welcome to the TOMI Environmental Solutions, Inc. 2025 financial results conference call. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions and comments following the presentation. It is now my pleasure to turn the floor over to your host, Zach Nevas from IMS Investor Relations. Zach, the floor is yours.
Thank you for joining us today for the TOMI Environmental Solutions Investor Update conference call. On today's call is TOMI CEO and Chairman, Dr. Halden Shane, EJ Shane, our Chief Operating Officer, and our Chief Financial Officer, David Vanston. A telephone replay of today's call will be available April 7th, 2026. The details of which are included in the company's press release dated March 31st, 2026. A webcast replay will also be available at TOMI's website, www.steramist.com. Certain written and oral statements made by TOMI may constitute forward-looking statements as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
